Heba Attia
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Advanced Drug Delivery Systems 3
- Co-authors
- Sadek Ahmed (9 shared papers)Ramy K. Aziz (5 shared papers)Mohamed A. Farag (2 shared papers)Martin von Bergen� (1 shared paper)Osama Saher (3 shared papers)Islam M. Adel (5 shared papers)Masun Nabhan Homsi (1 shared paper)Abdurrahman M. Fahmy (4 shared papers)
- Journals
- International Journal of Pharmaceutics X (5 papers)Journal of Drug Delivery Science and Technology (3 papers)AAPS PharmSciTech (2 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (2 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- EgyptSwedenSaudi Arabia
In The Last Decade
Heba Attia
19 papers receiving 270 citations
Heba Attia's Hit Papers
Peers
Comparison fields: 5 of 63
- Pharmaceutical Science 45
- Biochemistry 27
- Molecular Medicine 16
- Applied Microbiology and Biotechnology 3
- Otorhinolaryngology 6
Countries citing papers authored by Heba Attia
This map shows the geographic impact of Heba Attia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Attia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Attia more than expected).
Fields of papers citing papers by Heba Attia
This network shows the impact of papers produced by Heba Attia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Attia. The network helps show where Heba Attia may publish in the future.
Co-authors
The 23 scholars most cited alongside Heba Attia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 70 | |
| 2 | 2019 | 33 | |
| 3 | 2024 | 19 | |
| 4 | Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation Hit paper breakdown → | 2025 | 19 |
| 5 | Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation. Hit paper breakdown → | 2025 | 18 |
| 6 | 2025 | 15 | |
| 7 | 2025 | 14 | |
| 8 | 2023 | 13 | |
| 9 | 2025 | 12 | |
| 10 | 2019 | 9 | |
| 11 | 2023 | 9 | |
| 12 | 2025 | 8 | |
| 13 | 2025 | 7 | |
| 14 | 2025 | 6 | |
| 15 | 2025 | 6 | |
| 16 | 2026 | 5 | |
| 17 | 2026 | 4 | |
| 18 | 2025 | 2 | |
| 19 | 2024 | 2 | |
| 20 | L-forms of Staphylococcus aureus as a cause of resistant conjunctivitis. | 1978 | 1 |
About Heba Attia
Heba Attia is a scholar working on Molecular Biology, Pharmaceutical Science, Ophthalmology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 22 papers that have together received 272 indexed citations. Recurring topics across this work include Ocular Infections and Treatments (4 papers), Ocular Surface and Contact Lens (3 papers), Advanced Drug Delivery Systems (3 papers), Antibiotic Resistance in Bacteria (2 papers), Neuropeptides and Animal Physiology (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Cancer Genomics and Diagnostics (1 paper) and Corneal Surgery and Treatments (1 paper). The work is most often cited by research in Pharmaceutical Science (45 citations), Biochemistry (27 citations), Molecular Medicine (16 citations), Applied Microbiology and Biotechnology (3 citations) and Otorhinolaryngology (6 citations). Heba Attia has collaborated with scholars based in Egypt, Sweden and Saudi Arabia. Frequent co-authors include Sadek Ahmed, Ramy K. Aziz, Mohamed A. Farag, Martin von Bergen�, Osama Saher, Islam M. Adel, Masun Nabhan Homsi, Abdurrahman M. Fahmy, Aymen S. Yassin and Jonathan M. Monk. Their work appears in journals such as International Journal of Pharmaceutics X, Journal of Drug Delivery Science and Technology, AAPS PharmSciTech, Naunyn-Schmiedeberg s Archives of Pharmacology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.